Sangamo Therapeutics Inc (LTS:0R1D)
$ 2.18 -0.06 (-2.68%) Market Cap: 492.41 Mil Enterprise Value: 480.93 Mil PE Ratio: 0 PB Ratio: 12.55 GF Score: 41/100

Q1 2019 Sangamo Therapeutics Inc Earnings Call Transcript

May 08, 2019 / 09:00PM GMT
Release Date Price: $13.28
Operator

Good day, ladies and gentlemen, and welcome to the Sangamo First Quarter 2019 Teleconference Conference Call. (Operator Instructions) As a reminder, this call will be recorded. I would now like to introduce your host for today's conference, McDavid Stilwell. Please go ahead.

McDavid Stilwell
Sangamo Therapeutics, Inc. - VP of Corporate Communications & IR

Hello. Thank you for joining us. As we begin, I'd like to point out that we posted our May corporate presentation to our website and will be referencing several of these slides today. A link to the slide presentation may be found on our website, sangamo.com, on the Events and Presentations page of the Investors and Media section of the site. I'd also like to remind everyone that the projections and forward-looking statements that will be discussed during this conference call are based upon the information that we have available today. Forward-looking statements include, but are not limited to statements related to the potential therapeutic applications for Sangamo's genomic medicine platform, the potential

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot